Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Company Announcement: MACQUARIE GROUP LIMITED

Singapore, April 27 -- MACQUARIE GROUP LIMITED made the following announcement: Security Name: MACQGRPLTD USD20MF270722 Coupon Payment::Mandatory (https://links.sgx.com/1.0.0/corporate-announcements... Read More


Singapore Company Announcement: PARK24 CO., LTD.

Singapore, April 27 -- PARK24 CO., LTD. made the following announcement: Security Name: PARK24 JPY35B Z280224 Annual Reports and Related Documents:: (https://links.sgx.com/1.0.0/corporate-announceme... Read More


Singapore Company Announcement: MIZUHO FINANCIAL GROUP, INC.

Singapore, April 27 -- MIZUHO FINANCIAL GROUP, INC. made the following announcement: Security Name: MIZUHOFIN US$1.4B1.234%N270522 Issuer's Early Redemption (Call Option)::Mandatory (https://links.s... Read More


Singapore Company Announcement: DBS BANK LTD.

Singapore, April 27 -- DBS BANK LTD. made the following announcement: Security Name: DBS BANK USD100M F261023 Coupon Payment::Mandatory (https://links.sgx.com/1.0.0/corporate-announcements/9S5FKIZ21... Read More


Singapore Company Announcement: DBS BANK LTD., AUSTRALIA BRANCH

Singapore, April 27 -- DBS BANK LTD., AUSTRALIA BRANCH made the following announcement: Security Name: DBS BANK A$675M F260721 Coupon Payment::Mandatory (https://links.sgx.com/1.0.0/corporate-announ... Read More


Singapore Company Announcement: TELIX PHARMACEUTICALS (INVESTMENTS) INC.

Singapore, April 27 -- TELIX PHARMACEUTICALS (INVESTMENTS) INC. made the following announcement: Security Name: TELIXPHAR(I)US$600M1.5%N310422 Debt - Listing Confirmation::U.S.$600,000,000 1.50 PER ... Read More


Singapore Company Announcement: SOMPO HOLDINGS, INC.

Singapore, April 27 -- SOMPO HOLDINGS, INC. made the following announcement: Security Name: MULTIPLE Debt - Listing Confirmation::US$1,300,000,000 5.411% SENIOR CALLABLE FIXED-TO-FIXED RESET RATE NO... Read More